These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38809304)
1. Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment? Lubarsky M; Hernandez AE; Collie BL; Westrick AC; Thompson C; Kesmodel SB; Goel N Breast Cancer Res Treat; 2024 Aug; 206(3):509-517. PubMed ID: 38809304 [TBL] [Abstract][Full Text] [Related]
2. Structural Racism and Breast Cancer-specific Survival: Impact of Economic and Racial Residential Segregation. Goel N; Westrick AC; Bailey ZD; Hernandez A; Balise RR; Goldfinger E; Antoni MH; Stoler J; Kesmodel SB; Kobetz EN Ann Surg; 2022 Apr; 275(4):776-783. PubMed ID: 35081560 [TBL] [Abstract][Full Text] [Related]
3. Residential segregation and overall survival of women with epithelial ovarian cancer. Westrick AC; Bailey ZD; Schlumbrecht M; Hlaing WM; Kobetz EE; Feaster DJ; Balise RR Cancer; 2020 Aug; 126(16):3698-3707. PubMed ID: 32484923 [TBL] [Abstract][Full Text] [Related]
4. Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study. Herbach EL; Curran M; Roberson ML; Carnahan RM; McDowell BD; Wang K; Lizarraga I; Nash SH; Charlton M Cancer Causes Control; 2024 Jul; 35(7):1017-1031. PubMed ID: 38546924 [TBL] [Abstract][Full Text] [Related]
5. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care. Dinicu AI; Dioun S; Wang Y; Huang Y; Wright JD; Tergas AI Gynecol Oncol; 2024 May; 184():214-223. PubMed ID: 38340647 [TBL] [Abstract][Full Text] [Related]
6. Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt. Bonner SN; Clark C; Keating NL; Kouri EM; Freedman RA Clin Breast Cancer; 2019 Jun; 19(3):178-187.e3. PubMed ID: 30685264 [TBL] [Abstract][Full Text] [Related]
7. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago. Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584 [TBL] [Abstract][Full Text] [Related]
8. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Chen L; Li CI Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428 [TBL] [Abstract][Full Text] [Related]
9. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825 [TBL] [Abstract][Full Text] [Related]
10. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy. Wu X; Richardson LC; Kahn AR; Fulton JP; Cress RD; Shen T; Wolf HJ; Bolick-Aldrich S; Chen VW J Natl Med Assoc; 2008 May; 100(5):490-8. PubMed ID: 18507201 [TBL] [Abstract][Full Text] [Related]
11. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States. Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025 [No Abstract] [Full Text] [Related]
12. Neighborhood-Level Redlining and Lending Bias Are Associated with Breast Cancer Mortality in a Large and Diverse Metropolitan Area. Collin LJ; Gaglioti AH; Beyer KM; Zhou Y; Moore MA; Nash R; Switchenko JM; Miller-Kleinhenz JM; Ward KC; McCullough LE Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):53-60. PubMed ID: 33008873 [TBL] [Abstract][Full Text] [Related]
13. Measures Matter: The Local Exposure/Isolation (LEx/Is) Metrics and Relationships between Local-Level Segregation and Breast Cancer Survival. Bemanian A; Beyer KM Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):516-524. PubMed ID: 28325737 [No Abstract] [Full Text] [Related]
14. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150 [TBL] [Abstract][Full Text] [Related]
16. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Poulson MR; Beaulieu-Jones BR; Kenzik KM; Dechert TA; Ko NY; Sachs TE; Cassidy MR Ann Surg; 2021 Jan; 273(1):3-9. PubMed ID: 32889878 [TBL] [Abstract][Full Text] [Related]
17. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer. Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877 [TBL] [Abstract][Full Text] [Related]
18. Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Kershaw KN; Osypuk TL; Do DP; De Chavez PJ; Diez Roux AV Circulation; 2015 Jan; 131(2):141-8. PubMed ID: 25447044 [TBL] [Abstract][Full Text] [Related]
19. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta. Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA; Lin J; McCullough LE J Natl Compr Canc Netw; 2021 Aug; 19(11):1242-1251. PubMed ID: 34399407 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer survival, survival disparities, and guideline-based treatment. Hill DA; Friend S; Lomo L; Wiggins C; Barry M; Prossnitz E; Royce M Breast Cancer Res Treat; 2018 Jul; 170(2):405-414. PubMed ID: 29569018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]